ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19
Bruna G.G. Pinto, Antonio E.R. Oliveira, Youvika Singh, Leandro Jimenez, Andre N A. Gonçalves, Rodrigo L.T. Ogava, Rachel Creighton, Jean Pierre Schatzmann Peron, View ORCID ProfileHelder I. Nakaya
doi: https://doi.org/10.1101/2020.03.21.20040261
Bruna G.G. Pinto
1Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
Antonio E.R. Oliveira
1Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
Youvika Singh
1Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
Leandro Jimenez
1Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
Andre N A. Gonçalves
1Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
Rodrigo L.T. Ogava
1Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
Rachel Creighton
2Department of Bioengineering, University of Washington, Seattle, WA, USA
Jean Pierre Schatzmann Peron
3Neuroimmune Interactions Laboratory – Department of Immunology – Institute of Biomedical Sciences - University of Sao Paulo, Sao Paulo, Brazil. CEP 05508-000
4Scientific Platform Pasteur USP, São Paulo, Brazil
Helder I. Nakaya
1Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
4Scientific Platform Pasteur USP, São Paulo, Brazil
Data Availability
All data can be found in Table S1.
Posted March 27, 2020.
ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19
Bruna G.G. Pinto, Antonio E.R. Oliveira, Youvika Singh, Leandro Jimenez, Andre N A. Gonçalves, Rodrigo L.T. Ogava, Rachel Creighton, Jean Pierre Schatzmann Peron, Helder I. Nakaya
medRxiv 2020.03.21.20040261; doi: https://doi.org/10.1101/2020.03.21.20040261
ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19
Bruna G.G. Pinto, Antonio E.R. Oliveira, Youvika Singh, Leandro Jimenez, Andre N A. Gonçalves, Rodrigo L.T. Ogava, Rachel Creighton, Jean Pierre Schatzmann Peron, Helder I. Nakaya
medRxiv 2020.03.21.20040261; doi: https://doi.org/10.1101/2020.03.21.20040261
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)